We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Oncology and
1 other channel

Journal Scan / Research · May 05, 2022

Canakinumab vs Placebo in Children and Young Adults With Sickle Cell Anemia

Blood

 

 Save  Recommend
 Share

Additional Info

Blood
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia
Blood 2022 Feb 28;[EPub Ahead of Print], DC Rees, Y Kilinc, S Unal, CD Dampier, B Pace, B Kaya, S Trompeter, I Odame, J Mahlangu, S Unal, J Brent, R Grosse, B Fuh, BP Inusa, A Koren, G Leblebisatan, C Levin, E McNamara, K Meiser, D Hom, SJ Oliver

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated